Central and Southern Asia vs Turkmenistan: Proportion of the target population who received a 3rd dose of
Central and Southern Asia
89.0%
in 2024
Turkmenistan
99.0%
in 2024
Central and Southern Asia rank
2nd
Turkmenistan rank
1st
Proportion of the target population who received a 3rd dose of over time
- Central and Southern Asia
- Turkmenistan
How they compare
Turkmenistan currently reports 99.0% against 89.0% in Central and Southern Asia, a difference of 10.0%.
That makes Turkmenistan's figure about 1.1 times Central and Southern Asia's.
The two have swapped places 1 time across 5 shared years of data; in 2020 it was Central and Southern Asia ahead.
Central and Southern Asia ranks 2nd and Turkmenistan ranks 1st of 37 groups.
Turkmenistan has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Central and Southern Asia or Turkmenistan?
- Turkmenistan, at 99.0% against 89.0% in Central and Southern Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Central and Southern Asia and Turkmenistan?
- 10.0%, with Turkmenistan ahead.
- How many years of comparable data are there for Central and Southern Asia and Turkmenistan?
- 5 years are reported by both, from 2020 to 2024.
- How do Central and Southern Asia and Turkmenistan rank globally for proportion of the target population who received a 3rd dose of?
- Central and Southern Asia ranks 2nd and Turkmenistan ranks 1st of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.